Loading...
 

Volume 35, Issue 1, March 2024



Sign in to download the Issue in PDF format.

Mediterr J Rheumatol 2021;32(1):66-73
Development of an Educational Video for Self-Assessment Of Patients with RA: Steps, Challenges, and Responses
Authors Information

1. Saint-Joseph University, Beirut, Lebanon
2. Weill Cornell Medicine, Doha, Qatar
3. Cairo University, Cairo, Egypt
4. Al-Bashir Hospital, Amman, Jordan
5. Heartbeat Clinic, Beirut, Lebanon
6. Levant Hospital, Beirut, Lebanon
7. Hamad Medical Corporation, Doha, Qatar
8. King Hussein Medical Center, Amman, Jordan
9. Dr Humeira Badsha Medical Center, Dubai, United Arab Emirates
10. Specialized Medical Center, Riyadh, Saudi Arabia
11. King Faisal Specialist Hospital, Jeddah, Saudi Arabia
12. Mediclinic City Hospital, Dubai, United Arab Emirates
13. American University of Beirut, Beirut, Lebanon
14. Lebanese University, Beirut
15. Holy-Spirit University, Kaslik, Lebanon
16. Monla Hospital, Tripoli, Lebanon
17. Al-Zahraa Hospital, Beirut, Lebanon
18. Assiut University, Egypt and King Hamad University Hospital, Bahrain
19. Z-Clinic, Beirut, Lebanon
20. Jordan Hospital, Amman, Jordan

Nelly Ziade

Abstract

Objectives: The primary objective was to develop an educational video to teach patients with rheumatoid arthritis (RA) self-assessment of their disease activity. Secondary objectives were to validate the video, identify the challenges in producing it, and the responses to these challenges. Methods: Rheumatologists from 7 Middle Eastern Arab countries (MEAC) discussed unmet needs in the education of patients with RA. They reviewed pre-existing educational audiovisual material and drafted the script for a new video in Arabic. The video was produced in collaboration with a technical team, then validated by patients using a standardized interview. At each step of production, challenges were identified. Results: Twenty-three rheumatologists from MEAC identified unmet needs in patients’ education. A video was produced, explaining the concepts of treat-to-target and showing a patient performing self-assessment using DAS-28. Sixty-two patients were interviewed for validation and found the video to be useful and easy to understand, albeit not replacing the physician’s visit. Most common challenges encountered included acceptance of patient empowerment, agreement on DAS-28 as composite measure, production of a comprehensible written Arabic text, and addressing the population cultural mix. ConclusionDespite challenges, the video was well accepted among patients and can be used for clinical and research purposes. It is particularly useful in pandemic periods where social distancing is recommended.


Article Submitted: 5 Jul 2020; Revised Form: 6 Sep 2020; Article Accepted: 15 Oct 2020; Available Online: 4 Mar 2021

https://doi.org/10.31138/mjr.32.1.66

This work is licensed under a Creative Commons Attribution 4.0 International License (CC-BY). 

©Ziade N, Arayssi T, El-Zorkany B, Aiko A, Abi Karam G, Abu Jbara M, et al.

Full Text

INTRODUCTION

Rheumatoid Arthritis (RA) is the most frequent chronic rheumatic inflammatory disease, with an estimated prevalence of 0.24 to 1.25% in the adult population. Untreated, RA may lead to severe progressive joint destruction, functional disability, and premature mortality.1-3

Over the last decade, the concept of treat-to-target (T2T) revolutionized RA management and improved disease prognosis.4,5 First published in 2010, the main pillars of the T2T recommendations are the definition of a treatment target, the assessment of disease activity using composite measures, the modification of treatment if the target is not achieved within a specific timeframe, and the consideration of individual patient characteristics and shared decision-making.6,7

The use of composite disease measures are critical to the success of T2T,8,9 and their use in daily practice is recommended by major rheumatology associations such as the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR).10,11 Such measures include thewidely used Disease Activity Score (DAS-28), or the more recent scales, the Clinical Disease Activity Index (CDAI), and the  Simplified Disease Activity Index (SDAI).12,13 All three correlate almost linearly with each other and with impairment in physical function.14,15

Although helpful, collecting these indices regularly in daily practice by the healthcare providers is time-consuming. Thus, involving the patient in the self-assessment of their joint count may expedite the evaluation process during their clinic visits. Moreover, empowering the patient, through education, improves the perception of disease activity in-between visits and enhances treatment adherence.16

With the help of new technologies, several self-assessment tools were recently developed and are available through interactive e-health platforms, web applications, and smartwatches. They allow the monitoring of patients between consultations and assist in making more informed treatment decisions. They are becoming a cornerstone of the emerging telemedicine movement, especially during times where social distancing is recommended, such as the COVID-19 pandemic.17-22

However, the optimal format for teaching self-assessment to patients is still debated. Using audiovisual material, such as videos, is one effective method to convey complicated medical concepts in a simple and accessible manner to a layperson.23 Video-assisted patient education has also shown efficacy in modifying patient behavior, especially when using a model patient enacting a behavior.23 The video format is time-efficient, round-the-clock accessible, and allows the learners to proceed at their own pace.24

The National Rheumatoid Arthritis Society (NRAS) and the Cochin hospital’s team developed each an educational video in English and French, respectively, to teach RA patients self-assessment of their disease activity using DAS-28.25,26 The videos are around 20 minutes long and feature a healthcare provider explaining the T2T concept, followed by a patient performing self-assessment of 28 joints. To our knowledge, no such material was developed and adapted in the Arabic language.

The objective of our study is to develop an educational video, in Arabic, to teach patients with RA self-assessment of their disease activity using DAS-28. Secondary objectives are to validate the video, identify challenges in producing it, and to discuss responses to these challenges.

 

MATERIALS AND METHODS

Identification of unmet needs in the education of patients with RA

Rheumatologists (“study team”) from seven Middle Eastern Arab countries (MEAC: Bahrain, Egypt, Jordan, Lebanon, Qatar, Saudi Arabia, and the United Arab Emirates) were invited through emails to participate in the project. The study team met in-person during a regional rheumatology meeting to identify the unmet needs in patient education in the Middle East and to delineate the ideal formats to address these needs. The development of a culturally appropriate educational video was identified as a priority, and a roadmap was created for its production.

 

Development of the patient education video

A list of evidence-based guiding principles (Table 1) was used to develop the video.16,24,27-35 Pre-existing educational audiovisual material was identified through a search of the literature, of patients’ associations’ websites and social media platforms. Two videos addressing self-assessment using DAS-28 were found and reviewed by the study team. The first is published online in English by the NRAS, and the second in French by the Cochin hospital’s team, under the auspices of the French Society of Rheumatology.25,26 The strengths and weaknesses of these videos, as well as the appropriateness for the Middle Eastern cultural setting, were discussed by the study team, a rheumatology nurse, and a medical student.  Based on the discussion, a script for the video was drafted. The physical exam section was transcribed from the French language video, translated into Arabic by the study team, and then reviewed by a professional translator for clarity of the language. A patient with RA was then invited to participate in to be the model/ actress in the video. Then, with the help of a professional technical team (comprising a movie director and an editor, with a vast experience of filming in several Arab countries, and a qualified voice-over expert), the video scenario was planned. This included choosing the video setting, the movie cuts sequence, and the patient’s clothing. On the day of filming, a rheumatologist (NZ) and a nurse (NS) were present on site. The video was edited in a professional studio in the presence of a rheumatologist (NZ) and a medical student (AD).


Table 1. List of guiding principles for developing an educational video.
 

 

Evaluating the patients’ perceptions about the video

First, the video was reviewed for accuracy and clarity by the study team through multiple email rounds. Then, a sample of consecutive Arabic speaking patients with RA from 6 MEAC was invited by their rheumatologist to participate in evaluating the video. The rheumatologist explained the purpose of the video and obtained consent from the patients. In a separate room, the patients viewed the video and were interviewed by a trained rheumatology nurse who collected the patients’ feedback about the clarity of the video, acceptance, ability, and willingness to self-assess (Figure 1).

The study was approved by the Central Ethics Committee of Saint-Joseph University, Beirut, Lebanon, and by all local the Ethics Committees of the participating sites. All patients signed an informed consent form prior to enrollment in the study.


Figure 1. Flowchart of the successive steps of the educational video production: from designing to validation.
 

 

RESULTS

Identification of unmet needs in the education of patients with RA

Twenty-three rheumatologists from 7 MEAC participated in the study. All agreed that several gaps exist in patient education for rheumatic diseases, particularly for RA. The top two gaps identified were: 1) the patient’s difficulty in understanding the chronic nature of rheumatic diseases, and 2) the low adherence to prescribed regimens, especially after the symptoms have improved. Those gaps were deemed as a priority as they are tightly related to disease prognosis. Moreover, the study team agreed that, although the use of objective composite measures for assessment of disease activity in RA was desirable and can improve patients’ outcomes, their implementation can be highly time-consuming in daily practice. Therefore, developing appropriate educational material that involves patients in their disease management strategy was considered a priority by the study team.

The study team then discussed and resolved several challenges before proceeding into the stage of video development. The first was to decide on the choice of the disease activity measure to be used in the video. The following measures were discussed: DAS-28, CDAI, and SDAI. Although DAS-28 has some limitations, it was strongly recommended by the majority of the study team as it is the most widely used and includes joint counts, inflammatory markers, and patient’s global assessment.36,37

The second challenge was accepting the idea of patient empowerment and participation in their disease management. Several rheumatologists, especially those working in the private healthcare sector, raised their concern about whether promoting patient self-assessment could lead to a decrease in the frequency of patients visits and a decline in their income. This could be a valid concern, yet the purpose of promoting self -assessment is to complement the physician’s evaluation, decrease the visit time, and motivate the patient’s adherence to the therapeutic strategy.

The third challenge was the skepticism of some members of the study team about patients’ adherence to the skills taught in the video. It was agreed that the rheumatologist should use their judgment in selecting the suitable candidate-patient to whom self-assessment would be offered.

 

Development of the patient education video

The two videos from NRAS and Cochin had detailed content and were used as reference documents. Both NRAS and Cochin team provided permission to use the videos for information. However, the study team felt that both videos were too long (around 20 minutes), that some sections used technical terms that may be difficult to understand, and that the choice of clothing of the model may not be acceptable by all cultures in the region. Also, both videos were relatively difficult to access, requiring an internet connection or a DVD player. Thus, the study team decided to create a new video in Arabic that would be shorter in duration, uses less technical terms, and better aligns with the local culture. Moreover, the video was designed in a user-friendly format and accessible without the need for an Internet connection.

The study team wrote the script for the video. The script was then reviewed by a professional translator for accuracy. To simplify the medical terms used in the video and make them understandable by the majority of the patients who speak the different Arabic dialects, the study team, using euphonic nomenclatures, translated these terms based on their dialect. Then, they reached a consensus on which translation should be included in the video.

The choice of the actor’s gender and clothing was also a matter of debate by the study team. Taking into consideration that the target audience is middle-aged women with diverse cultural and religious beliefs, a middle-aged female RA patient, with previous experience in television advertising, was selected for the role. The patient/actor wore neutral, conservative, and dark clothing for the filming. Prior to filming, she received a detailed briefing by her rheumatologist on self-assessment of disease activity. 

The video was filmed in a traditional home setting in the presence of a professional technical team, a rheumatologist, and a nurse. Then, the best video cuts were selected by the technical team. The cuts went through editing, voice cover, musical cover, and subtitling phases. The duration of the video was seven minutes, which was significantly shorter than the reference videos. English subtitles were prepared by the translator and reviewed and approved by the study team through multiple email rounds.

The new video was made easily transferable to the patient’s cellular phone and accessible without the need for an internet connection. The video can be accessed at this link: https://www.youtube.com/results?search_query=autodas+meac.

After completion of the video and in collaboration with a graphic designer, a supplementary cartoon version, depicting a male character, was also created as an alternative to be used for male patients and patients from more conservative populations.

 

Evaluating the patients’ perceptions about of the video

After the study team approved the video, a sample of 62 consecutive RA patients attending the rheumatology clinics of the study team participated in the validation of the video. All patients were keen to be educated about their disease management and to understand the treatment decision algorithm followed by their physicians. However, several were reluctant to accept that they can accurately self-assess, and most stated that it would not replace the doctor’s visit. Ninety-six percent found the section of the video explaining the self-joint examination was easy to understand. Forty-one percent of the patients, however, found the scoring to be challenging and needed practice and support from the physician or the nurse. Most of the patients (76%) reported that self-assessment would not totally replace the doctor’s visit.

Several challenges were identified during the development of the video and its validation (Table 2). First, it was challenging for patients to feel confident in the accuracy of their assessment. They were reassured that their self-assessment will not replace the rheumatologist’s assessment but rather than help them make more informed therapeutic decisions.

Second, several patients found the scoring to be challenging. This was facilitated by providing several practice sessions by the physician or study nurse that helped improve their skills and confidence.

Third, it was challenging to find an unbiased source of funding. Thus, to complete the project, all centers graciously volunteered to participate in the study without financial compensation. All study group meetings were aligned with local, regional, or international conferences.


Table 2. Challenges and responses through the development of the video, at the different levels: rheumatologist, patient, cultural and logistics.
 
 
 

DISCUSSION

The production of an educational video in Arabic for self-assessment of disease activity for patients with RA was successfully implemented.

This was primarily facilitated by the collaboration between rheumatologists from several Arab countries, as witnessed in previous RA projects.38 Additional important enablers were adhering to the evidence-based guiding principles for developing educational videos16,24,28 and identifying the unmet needs for  RA patient education by the study group.39,40 Moreover, the availability of two previous videos25,26 allowed recognizing a priori strengths and weaknesses in each video, which helped improve the current video. Finally, the inclusion of patients in the validation phase added to its pertinence and applicability.

A major advantage of the produced video was the collaboration between a highly experienced team of rheumatologists and a professional technical team. This collaboration lead to a script that was understandable in most Arab countries and visuals that are culturally appropriate to the Middle East region. The English subtitles made the video also accessible to non-Arab speaking expatriate patients living in Arab countries. Moreover,  having a real patient acting in the video facilitated the acceptance by the target patients’ population.23,24,28

Furthermore, as compared to the Cochin and NRAS video, the video was relatively short in duration, downloadable on a smartphone, and accessible without the need of an internet connection, making it easier to watch repeatedly. Finally, if needed at a later stage, the video can be easily modified and adapted for use by other populations.

The outcome of educational videos on several different topics, such as education about pneumococcal vaccination41 and cervical cancer health literacy,42 was a clear impact on changing patients’ behaviors positively. Also, the above videos, as well as the NRAS and Cochin RA videos,26,43,44 were well received by the patients who appreciated the education offered to them.

The video format is relatively expensive to produce, and its creation is time-consuming. However, it remains an accessible source of education to most of the patients and allows them to watch it repetitively at their own pace, from the comfort of their home.24

The study also has several limitations. The choice of DAS-28 as the outcome measure may be questioned.36,45 DAS-28 is strongly associated with both inflammation and patient-reported outcomes.36 However, the subjectivity related to the patient global assessment and the possible variability of the biological inflammatory markers, which may be elevated due to causes other than RA, may have an impact on the stability of the final score. Moreover, DAS-28 calculation may be complicated for the layperson and needs a special calculator. In case patients were resistant to calculating a composite score, the concordance of more intuitive scores, such as CDAI and SDAI, may be used as alternatives in the future. The video may be easily adapted to editing the final section on scoring.

Another limitation is the generalisability of the video to different patient populations.  Patients with low levels of education may find the video difficult to use and, therefore, may not fully benefit from this educational intervention. Finally, patients who may be known to be non-compliant to treatment may use the self-assessment as an excuse to skip important and irreplaceable visits to the rheumatologist. Although this was not reflected in the patient interview, the clinical judgment of the rheumatologist should guide the selection of patients to whom the video will be offered and how it will be used. Empowering patients to self assess their disease activity might be viewed as a double-edged sword to some physicians. They might fear some loss of income by losing the visits of patients who can self-assess their disease. In our opinion, and in the setting of a busy practice, the precious time saved can provide additional consultation time slots to offer care for more patients in more need to see the rheumatologist, potentially increasing both income and patient satisfaction.

 

CONCLUSION

The collaboration between several countries sharing the same language, close cultural backgrounds, and comparable unmet needs was possible and able to produce an educational material in lay language aiming at self-assessment of patients with RA. Many challenges were faced at every step of the production and were resolved through consensus and teamwork. The video may serve for future research and clinical purposes, according to the rheumatologist’s clinical judgment.

AUTHOR CONTRIBUTION

NZ designed and coordinated the study. All the authors contributed substantially to the work, revised the manuscript critically, approved the submitted version, and agree to be accountable for all aspects of the work.

 

ACKNOWLEDGMENTS

  • Professor Maxime Dougados for providing the French video and for sharing valuable advice.
  • NRAS for providing the English video.
  • Ms Nancy Fahed, for the professional Arabic translation.
  • M. Georgic Khacha, Gr8 movies, for directing the video and creating the YouTube and WhatsApp versions.
  • M. Tony Sassy for the voice-over.

 

CONFLICT OF INTEREST

The authors declare no conflict of interest.

 

ETHICS APPROVAL

The study was approved by the Central Ethics Committee of Saint-Joseph University, Beirut, Lebanon, and by all local the Ethics Committees of the participating sites. All patients signed an informed consent form prior to enrollment in the study.

References
  1. Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet 2016;388:2023-38.
  2. Rudan I, Sidhu S, Papana A, Meng S-J, Xin-Wei Y, Wang W, et al. Prevalence of rheumatoid arthritis in low- and middle-income countries: A systematic review and analysis. J Glob Health 2015;5:010409.
  3. Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, et al. The global burden of rheumatoid arthritis: Estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis 2014;73:1316–22.
  4. Stoffer MA, Schoels MM, Smolen JS, Aletaha D, Breedveld FC, Burmester G, et al. Evidence for treating rheumatoid arthritis to target: Results of a systematic literature search update. Ann Rheum Dis 2016;75:16-22.
  5. Jurgens MS, Welsing PMJ, Jacobs JWG. Overview and analysis of treat-to-target trials in rheumatoid arthritis reporting on remission. Clin Exp Rheumatol Jul-Aug 2012;30(4 Suppl 73):S56-63.
  6. Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis 2015;75:3-15.
  7. Smolen JS, Aletaha D, Bijlsma JWJ, Breedveld FC, Boumpas D, Burmester G, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010;69:631–7.
  8. Lukas C, van der Heijde D, Fatenajad S LR. Repair of erosions occurs almost exclusively in damaged joints without swelling. Ann Rheum Dis 2010;69:851-5.
  9. Smolen JS, Han C, van der Heijde DMFM  et al. Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade. Ann Rheum Dis. 2009;68:823-7.
  10. Singh JA, Saag KG, Bridges SL, Akl EA, Bannuru RR, Sullivan MC, et al. 2015 American College of Rheumatology Guidelines for the Treatment of Rheumatoid Arthritis. Arthritis Care Res (Hoboken) 2016;68:1-25.
  11. Smolen JS, Landewé R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, et al. Eular Recommendations for the Management of Rheumatoid Arthritis With Synthetic and Biological Disease-Modifying Antirheumatic Drugs: 2016 Update. Ann Rheum Dis 2016;1-51.
  12. Prevoo MLL, Van’T Hof MA, Kuper HH, Van Leeuwen MA, Van De Putte LBA, Van Riel PLCM. Modified disease activity scores that include twenty‐eight‐joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
  13. Anderson JK, Zimmerman L, Caplan L MK. Measures of rheumatoid arthritis disease activity: patient (PtGA) and provider (PrGA) global assessment of disease activity, disease activity score (DAS) and disease activity score with 28-joint counts (DAS28), simplified disease activity index (SDAI), cl. Arthritis Care Res 2011;63:S14-36.
  14. Goekoop-Ruiterman YPM, De Vries-Bouwstra JK, Kerstens PJSM, Nielen MMJ, Vos K, Van Schaardenburg D, et al. DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis. Ann Rheum Dis 2010;69:65-9.
  15. Schipper LG, van Hulst LTC, Grol R, van Riel PLCM, Hulscher MEJL, Fransen J. Meta-analysis of tight control strategies in rheumatoid arthritis: Protocolized treatment has additional value with respect to the clinical outcome. Rheumatology 2010;49:2154-64.
  16. Zangi HA, Ndosi M, Adams J, Andersen L, Bode C, Boström C, et al. EULAR recommendations for patient education for people with inflammatory arthritis. Ann Rheum Dis 2015;74:954-62.
  17. McDougall JA, Ferucci ED, Glover J, Fraenkel L. Telerheumatology: A Systematic Review. Arthritis Care Res (Hoboken) 2017;69:1546-57.
  18. Grainger R, Townsley H, White B, Langlotz T, Taylor WJ. Apps for People With Rheumatoid Arthritis to Monitor Their Disease Activity: A Review of Apps for Best Practice and Quality. JMIR MHealth UHealth 2017;5:e7.
  19. Seppen BF, L’ami MJ, Duarte dos Santos Rico S, ter Wee MM, Turkstra F, Roorda LD, et al. A Smartphone App for Self-Monitoring of Rheumatoid Arthritis Disease Activity to Assist Patient-Initiated Care: Protocol for a Randomized Controlled Trial. JMIR Res Protoc 2020;9:e15105.
  20. Mcbain H, Shipley M, Olaleye A, Moore S, Newman S. A patient-initiated DMARD self-monitoring service for people with rheumatoid or psoriatic arthritis on methotrexate: A randomised controlled trial. Ann Rheum Dis 2016;75:1343-9.
  21. Van Riel P, Alten R, Combe B, Abdulganieva D, Bousquet P, Courtenay M, et al. Improving inflammatory arthritis management through tighter monitoring of patients and the use of innovative electronic tools. RMD Open 2016;2:1-9.
  22. Gossec L, Cantagrel A, Soubrier M, Berthelot J, Joubert J, Combe B, et al. Sanoïa®, plateforme e-santé interactive d’ auto-évaluation dans la polyarthrite rhumatoïde. Essai comparatif randomisé de 12 mois sur 320 patients. [Sanoïa® , an interactive self-assessment e-health platform for rheumatoid arthritis. Randomized controlled trial of 320 patients 12 months] Rev Rhum 2019;86:52-8. [Article in French]
  23. Abu Abed M, Himmel W, Vormfelde S, Koschack J. Video-assisted patient education to modify behavior: A systematic review. Patient Educ Couns 2014;97:16-22.
  24. The Ohio State University Medical. Effective Use of Audiovisual Materials [Internet]. 2006. Available from: https://ogg.osu.edu/media/documents/health_lit/effective_av.pdf
  25. Know your DAS - National Rheumatoid Arthritis Society [Internet]. [cited 2018 Nov 17]. Available from: https://www.nras.org.uk/patients
  26. Dougados M, Soubrier M, Perrodeau E, Gossec L, Fayet F, Gilson M. Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: Results of a prospective, multicentre, randomised, controlled trial (COMEDRA). Ann Rheum Dis 2015;74:1725-33.
  27. Fahrenwald NL, Belitz C, Keckler A. Outcome evaluation of “sharing the gift of life”: An organ and tissue donation educational program for American indians. Am J Transplant 2010;10:1453-9.
  28. Rosaasen N, Mainra R, Kukha-Bryson A, Nhin V, Trivedi P, Shoker A, et al. Development of a patient-centered video series to improve education before kidney transplantation. Patient Educ Couns 2018;101:1624-9.
  29. Canadian Institutes of Health Research. Canada’s Strategy for Patient-Oriented Research [Internet]. 2011. p. 1-36. Available from: https://cihr-irsc.gc.ca/e/44000.html
  30. Low JK, Crawford K, Manias E, Williams A. A compilation of consumers’ stories: The development of a video to enhance medication adherence in newly transplanted kidney recipients. J Adv Nurs 2016;72:813-24.
  31. Skelton SL, Waterman AD, Davis LA, Peipert JD, Fish AF. Applying best practices to designing patient education for patients with end-stage renal disease pursuing kidney transplant. Prog Transplant 2015;25:77-84.
  32. Jim HSL, Quinn GP, Gwede CK, Cases MG, Barata A, Cessna J, et al. Patient education in allogeneic hematopoietic cell transplant: What patients wish they had known about quality of life. Bone Marrow Transplant 2014;49:299-303.
  33. Massey EK, Tielen M, Laging M, Timman R, Beck DK, Khemai R, et al. Discrepancies between beliefs and behavior: A prospective study into immunosuppressive medication adherence after kidney transplantation. Transplantation 2015;99:375-80.
  34. Gordon EJ, Butt Z, Jensen SE, Lok-Ming Lehr A, Franklin J, Becker Y, et al. Opportunities for shared decision making in kidney transplantation. Am J Transplant 2013;13:1149-58.
  35. Urstad KH, Wahl AK, Andersen MH, Øyen O, Fagermoen MS. Renal recipients’ educational experiences in the early post-operative phase - a qualitative study. Scand J Caring Sci 2012;26:635-42.
  36. McWilliams DF, Kiely PDW, Young A, Joharatnam N, Wilson D, Walsh DA. Interpretation of DAS28 and its components in the assessment of inflammatory and non-inflammatory aspects of rheumatoid arthritis. BMC Rheumatol BMC Rheumatology 2018;2:8.
  37. Fransen J, Stucki G, van Riel PLCM. Rheumatoid arthritis measures: Disease Activity Score (DAS), Disease Activity Score-28 (DAS28), Rapid Assessment of Disease Activity in Rheumatology (RADAR), and Rheumatoid Arthritis Disease Activity Index (RADAI). Arthritis Rheum 2003;49:S214-24.
  38. Darzi A, Harfouche M, Arayssi T, Alemadi S, Alnaqbi KA, Badsha H, et al. Adaptation of the 2015 American College of Rheumatology treatment guideline for rheumatoid arthritis for the Eastern Mediterranean Region: An exemplar of the GRADE Adolopment. Health Qual Life Outcomes 2017 Sep 21;15(1):183.
  39. El Zorkany B, AlWahshi HA, Hammoudeh M, Al Emadi S, Benitha R, Al Awadhi A, et al. Suboptimal management of rheumatoid arthritis in the Middle East and Africa: Could the EULAR recommendations be the start of a solution? Clin Rheumatol 2013;32:151-9.
  40. Halabi H, Alarfaj A, Alawneh K, Alballa S, Alsaeid K, Badsha H, et al. Challenges and opportunities in the early diagnosis and optimal management of rheumatoid arthritis in Africa and the Middle East. Int J Rheum Dis 2015;18:268-75.
  41. Brown T, Goldman SN, Persell SD, Lee JY, Doan CT, Stephens Q, Baker DW, et al. Development and evaluation of a patient education video promoting pneumococcal vaccination. Patient Educ Couns 2017;100:1024-7.
  42. Montealegre JR, Gossey JT, Anderson ML, Chenier RS, Chauca G, Rustveld LO, et al. Implementing targeted cervical cancer screening videos at the point of care. Patient Educ Couns 2014;97:426-9.
  43. Shaffu S, Edwards J, Neame R, Hassan W. Self-assessment of 28-joint disease activity scores by patients with rheumatoid arthritis on anti-TNF therapy. Rheumatology (Oxford) 2013;52:576-8.
  44. Gossec L, Fayet F, Soubrier M, Foissac F, Molto A, Richette P, et al. Is self-assessment by patients of disease activity acceptable over the long term in rheumatoid arthritis? A 3-year follow-up of 771 patients. Rheumatology (Oxford) 2019;58:1498-9.
  45. Fransen J, van Riel PLCM. The Disease Activity Score and the EULAR response criteria. Clin Exp Rheumatol 2005;23:S93-9.